ProfileGDS5678 / 1445916_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 25% 20% 20% 19% 19% 20% 20% 20% 20% 20% 20% 20% 20% 20% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5990825
GSM967853U87-EV human glioblastoma xenograft - Control 22.4768620
GSM967854U87-EV human glioblastoma xenograft - Control 32.4788720
GSM967855U87-EV human glioblastoma xenograft - Control 42.4165319
GSM967856U87-EV human glioblastoma xenograft - Control 52.4202119
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5417620
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5051420
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4514220
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4429420
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4620820
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4614820
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4408620
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4701320
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4664520